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PO-0793   
Assessment of kV cone-beam CT dose, for children undergoing 
image-guided radiotherapy. 
R. Hansen1 
1Aarhus University Hospital, Medical Physics, Aarhus C, Denmark  
 
Purpose/Objective: Treatment plans for children undergoing 
radiation therapy become increasingly complex due to increased use 
of IMRT/arc therapy.This puts higher demands on patient positioning 
accuracy. Daily kV cone beam computed tomography (kVCBCT) is an 
excellent tool for this purpose, but it does also add an additional dose 
to normal tissue close to the treatment area. The purpose for this 
study was to determinate a quantitative method for the estimation of 
kVCBCT doses in pediatric patients undergoing image-guided 
radiotherapy. 
Materials and Methods: The dosimetric concept generally used in CT 
is basedon measurements of the computed tomography dose index 
(CTDI). The CTDI is measured with ionization chamber in a standard 
dosimetry phantom, and the effective dose and organ dose is 
calculated using a standard tool like the Excel-program CT Expo.There 
are several challenges in extending this method to CBCT, including 
definition of CTDI for a cone beam, different beam quality due to 
filtering, and the fact that CBCT can be limited to a 200° scan angle 
for head and neck modes. We have therefore measured dose in 
selected organs in anthropomorphic children phantoms corresponding 
to the age 1, 5 and 10 years with the romluminescence detectors 
(TLD). These measurements were compared to doses calculated by 
astandard CTDI approach/ CT Expo, and the differences assessed. 
Results: We found significant differences in the doses given bythe 
CTDI approach and direct measurements with TLDs. Especially this is 
true for the dose to lens, where the selected scan range for a 200° 
scan is the main contributing factor.  
Conclusions: The well-known methods from CT such as CTDI can not 
be directly adapted for kVCBCT images. In the absence of 
standardized absorbed dose metric comparable with the CTDI used in 
conventional CT, estimation of an effective dose should be calculated 
from point dose measurements with TLD detectors in anthropomorphic 
phantoms. In a clinical setting CBCT at an accelerator typically have 
only a few predefined settings of kV and mA depending on anatomical 
region. It is therefore advisable to keep a table over measured organ 
doses in anthropomorphic phantoms for standard clinical conditions as 
a reference.  
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Evaluating the usefulness of EPID for daily output verification by 
comparison to ionization chamber measurements 
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Purpose/Objective: To investigate the long term stability of the 
amorphous silicon electronic portal imaging device (aSi EPID) for 
monitoring medical linear accelerator output, by a) acquiring output 
data on a daily basis using the EPID, b) correlating EPID data to weekly 
measurements using an ionization chamber in a Perplex phantom and 
c) correlating as well as calibrating EPID response to absolute 
measurements with an ionization chamber in water. 
Materials and Methods: A test patient, including two open fields 
(25x25 cm2, 6 and 15 MV) intended for output measurements with the 
EPID, was defined. During a period of > 8 months, daily measurements 
were performed on 9 different medical linear accelerators (8 x Varian 
Clinac 2300iX and 1 x Varian TrueBeam), equipped with aSi EPIDs 
(Varian aS1000). Data from the EPID measurements was extracted, 
using a in-house software developed in MATLAB©, and compared to 
weekly output measurements with an ionization chamber in a Perplex 
phantom as well as to quarterly (or on indication) measurements with 
an ionization chamber in water. Calibration of the EPIDs were 
performed in conjunction with the ionization chamber measurements 
in water, also at which point the LINAC output was adjusted to within 
±0.3% of the reference data based on the measurements in water. 
Results: The ability of the EPID to detect output variation was 
confirmed by the correlation between the EPID measurements and the 
ionization chamber measurements in the Perplex phantom as well as 
in water (Figure 1), for both the Varian Clinac 2300iX as well as for 
the TrueBeam. However, a variation in performance between some 
EPIDs is present, possibly in some extent as a result of the differences 
in the wear and tear of the EPIDs. It is also clear that a daily variation 
of the EPID data exists and needs to be considered when selecting 
tolerance levels. Some of the EPIDs detected a greater increase in 
output over time in comparison to the increase in output detected by 
the ionization chamber measurements. However, regular calibration 
of the EPIDs in conjunction with the measurements in water proved to 
be a solution for this exception. 
 
 Figure1. Output deviation as a function of time for EPID, ionization 
chambermeasurements in a Perplex phantom (IC pp) and ionization 
chamber measurementsin a water phantom (IC wp). 
 
Conclusions: The Varian aSi EPID has been proven to be suitable for 
fast relative measurements of the LINAC output on a daily basis. 
However, regular (at least quarterly) calibrations of the EPIDs are 
essential for a clinic to be able to rely on the EPID as a quality 
assurance tool for daily verification of the LINAC output.The user 
independence and the fact that it is a two-dimensional detector 
mounted directly on the LINAC is some of the important advantages, 
giving also the possibility to readily verify beam quality, beam profile 
parameters (e.g. symmetry, flatness and field size) and MLC 
performance. 
 
 POSTER: PHYSICS TRACK: DOSE CALCULATION  
  
PO-0795   
Validation and one year experience with an independent redundant 
calculation software for VMAT fields 
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Purpose/Objective: It is accepted that the QA process previous to any 
treatment must include a redundant independent dose calculation. 
For conventional radiotherapy these calculations could even be 
performed manually using dosimetric data. On the other hand, for 
intensity modulated fields more complex software is required. 
Diamond ('K&S Associates') is a software with capabilities to calculate 
VMAT (Volumetric Modulated Arc Therapy) fields. Validation and one 
year experience for VMAT fields are presented in this work. 
Materials and Methods: For VMAT validation, a set of 59 clinically 
accepted plans was selected including different locations. The 
treatment planning system (TPS) used was Eclipse v10.0. First, the 
plans were recalculated on a cylindrical phantom. The recalculated 
plans were then exported to Diamond, where dose calculation was 
carried out at the isocenter. In Diamond, non-water equivalent 
relative electronic density of phantom was accounted for by setting 
an effective depth determined by the TPS. Results were analyzed 
obtaining average deviations and standard deviation values from the 
comparisons Diamond versus measurements and versus TPS. 
Experimental measurements were performed by using a pin-point 
chamber. In one year 476 VMAT plans were produced. These plans 
were grouped by location (abdomen, prostate, pelvis, torax, lung, 
brain, H&N, radiosurgery and SBRT), recalculated in the TPS without 
heterogeneity and then, exported to Diamond including body contour. 
A comparison between Diamond an Eclipse at isocenter was made. 
Results:  
Validation: An average dose deviation of –0.2 ± 1.7%(1SD) was 
obtained between Diamond and measurements. Only 2 of 59 values 
had a deviation above ±3.5% (+5.1 and -4.6%), a linear fit produced a 
correlation coefficient of 0.9945. Between Diamond and TPS the 
average deviation found was 0.0 ± 1.6%, correlation coefficient was 
0.9951. 
One year results: An average deviation of –0.3 ± 1.9% was obtained for 
the total of plans a linear fit produced a correlation coefficient of 
0.9991.Deviations greater than 4% was obtained in 7 plans and 
maximum deviation of +5.0% was obtained in one plan. 
It should be noted that a calculation point different from the 
isocenter was chosen in one case in the validation process to avoid 
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hight dose gradient regions. This same was made in 7 clinical plans. 
Also, 2 plans in validation and 8 plans in clinical practice were 
recalculated in an alternative phantom due to geometric 
uncertainties. 
Conclusions: The agreement between measurements and Diamond 
may be interpreted as an absence of systematic errors. In the same 
way the comparison between Eclipse and Diamond produced very 
similar results. One year experience shows results very close to those 
obtained in validation. This agreement led us to consider Diamond a 
valuable tool for QA in VMAT plans. 
   
PO-0796   
Independent dose calculation with X-ray Voxel Monte Carlo 
Algorithm in Volumetric Modulated Arc Therapy 
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Purpose/Objective: The MONACO treatment planning system (TPS) 
(Elekta), which employs an X-ray Voxel Monte Carlo (XVMC) algorithm 
is currently used in radiation therapy. The XVMC calculation is reliable 
for determining absorbed dose of X-ray in the heterogeneous region. 
Therefore, the MONACO TPS could be useful for an independent dose 
calculation in a high precision treatment. So, we developed a 
conversion program of a beam format in Pinnacle3 TPS to that in 
MONACO TPS. In this study, we present the dose comparison between 
them for prostate, lung, head and neck, and esophagus cancer 
patients treated by Volumetric Modulated Arc Therapy (VMAT). 
Materials and Methods: Eight patients (prostate; 5, lung; 1, head and 
neck; 1, esophagus; 1) treated by single-arc VMAT were selected for 
this study. The treatment plan was created by SmartArc (Pinnacle3, 
Philips) with the superposition/convolution algorithm. The calculation 
voxel space was 2 mm. Then, the beams from SmartArc were exported 
into the MONACO TPS, where the dose distribution was recalculated 
with 3 mm of the calculation voxel space and 3% of the variance. The 
comparison was performed by analysing the dose volume histogram 
(DVH) and the dose difference. 
Results: The differences in PTV D50 (covering 50% of the planning 
target volume) were about 0.6%, 1.4%, 1.2%, and 1.3% for prostate, 
lung, head and neck, and esophagus cancer cases, respectively. 
Although the dose difference tended to be relatively large for the 
organs at risk, the serious discrepancy was not observed. Figure shows 
one of the examples of the dose difference for a prostate cancer 
patient. 
 
  
Conclusions: It was feasible to use a commercially available TPS 
based on a Monte Carlo code as an independent dose calculation for 
VMAT. In this study, the dose comparison was performed in the 
various parts, so that no remarkable difference between the 
superposition/convolution calculation and XVMC calculation was 
found. 
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Stereobody for lung cancer: X-ray Voxel Monte Carlo vs Pencil 
Beam based dose calculation 
V. Landoni1, G. Borzì2, S. Strolin1, V. Bruzzaniti1, A. Soriani1, D. 
D'Alessio1, L. Strigari1 
1National Cancer Institute Regina Elena Rome Italy., Laboratory of 
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Purpose/Objective: The purpose of this study is to evaluate the 
differences between dose distributions calculated with Pencil Beam 
(PB) and X-ray Voxel Monte Carlo (XVMC) algorithm. Calculations 
performed with the PB algorithm is reasonably accurate for tumors 
located in homogeneous regions but PB tends to overestimate the 
dose distribution where large inhomogeneities exist. Moreover, for 
intensity modulated radiation therapy (IMRT) dose calculation can be 
more complex due to the combined effect of many small fields and 
the presence of steep fluence gradients.  
Materials and Methods: Treatment plans were developed for 45 lung 
cancer patients with iPlan, Brainlab. For each patient an IMRT or 
HybridArc plan calculated with PB algorithm was developed to give 40 
Gy at 8 Gy/ fraction with five no coplanar 6 MV beams or 3-4 dynamic 
conformal arcs with 3-5 IMRT beams distributed per arc (for HybridArc 
plans). Each optimized plan was recalculated with the XVMC algorithm 
with the same monitor units (MU). Secondly XVMC plans were 
renormalized to give the prescribed dose to the tumour and 
differences between MU to be delivered were evaluated. For four 
patients, evaluations have been performed also in the case of CT 
scans acquired under deep- breath condition. Differences in dose 
distributions were evaluated in terms of dose volume histograms 
(DVHs). To estimate the impact of the observed differences on 
treatment outcome, tumour control probability (TCP) and normal 
tissue complication probability (NTCP) were calculated. Thirdly a 
typical IMRT treatment plan was performed on CT data of an 
anthropomorphic phantom and calculated doses on significant planes 
were compared to measurements performed with GAFCHROMICTM 
EBT3.  
Results: Differences between mean tumour dose calculated with PB 
and XVMC were about 10±4 %, even larger in deep-breathing 
conditions, while differences between doses to significant volumes for 
organs at risk (OARs) were generally lower. After normalization, MUs 
for XVCM were always higher than for PB though not significantly (p = 
0.0531). TCP ranged from (99.9 ± 0.1) % to (87.1 ± 9.7) % for PB 
calculated plans respect to XVMC while NTCP on OARs did not vary 
significantly. In the deep-breathing condition TCP ranged from (99.9 ± 
0.3) % to (66.9 ± 17.2) % for PB and XVMC, respectively. The 
dosimetric evaluation confirmed the better accuracy in calculation of 
XVMC, the agreement in terms of absolute gamma function (gamma<1, 
3 %, 3mm) was about 94 % for XVMC and lowered down to 67 % for PB. 
Conclusions: Results showed that PB calculation leads to overestimate 
the dose with respect to the XVMC for the points inside the tumour, 
for each case the major discrepancies were observed along the 
boundary between tissue and air. The increase in MU due to the 
renormalization of the plans to have comparable mean doses to the 
tumour was not significant and the calculated NTCP values for OARs 
were far below the allowed tolerable values. 
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Purpose/Objective: Out-of-field dose to multiple organs has been 
evaluated for secondary cancer risk assessment using Monte Carlo 
calculation for breast preserving radiotherapy. Dose contributions 
from internal body scattering and linac head scattering have been 
separately calculated and compared. 
Materials and Methods: Monte Carlo codes, EGSnrc and 
DOSXYZnrc,were employed to evaluate out-of-field dose to various 
organs of breast cancer patients who received breast conserving 
radiotherapy. The out-of-field dose results from linac head scattering 
as well as internal body scattering ofdirect x-ray beams. These two 
scattering contributions were separately calculated by the Monte 
Carlo codes with a photon energy of 6 MV and a dosegrid size of 4 x 4 
x 6 mm3. Doses on the patient body surface and in various organs were 
calculated, whereas patient doses were also measured using glass rod 
dosimeters, GD-301 (Chiyoda Technol, Japan), in various body surface 
locations. To reduce statistical uncertainty, the number of photons 
was increased to 1 x 1010. To further verify the accuracy of the Monte 
Carlo calculation for the patient, surface and internal doses of RAND 
phantom were also calculated and compared to measured results 
using the glass rod dosimeter.  
 
